Puma Biotechnology Sees Q3 Sales $56.000M-$59.000M vs $60.500M Est
Benzinga Newsdesk 2 months ago
NewsGuidance
Puma Biotechnology (NASDAQ:PBYI) sees Q3 sales of $56.000 million-$59.000 million vs $60.500 million analyst estimate.
Puma Biotechnology (NASDAQ:PBYI) sees Q3 sales of $56.000 million-$59.000 million vs $60.500 million analyst estimate.